Colin Baigent leads the CTSU's Vascular Overviews Group, which recently reported a meta-analysis of the findings among 170,000 participants in 26 randomised trials of cholesterol-lowering drugs in The Lancet.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
This website doesn't track the visitors or use any cookies. Made by Alex Barredo. Send your feedback to alex@barredo.es.
